These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 23749170)
1. Ganglioside GM3 promotes HGF-stimulated motility of murine hepatoma cell through enhanced phosphorylation of cMet at specific tyrosine sites and PI3K/Akt-mediated migration signaling. Li Y; Huang X; Zhong W; Zhang J; Ma K Mol Cell Biochem; 2013 Oct; 382(1-2):83-92. PubMed ID: 23749170 [TBL] [Abstract][Full Text] [Related]
2. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway. Li Y; Huang X; Zhang J; Li Y; Ma K Int J Biochem Cell Biol; 2013 Nov; 45(11):2349-58. PubMed ID: 23968914 [TBL] [Abstract][Full Text] [Related]
3. Ganglioside GM3 exerts opposite effects on motility via epidermal growth factor receptor and hepatocyte growth factor receptor-mediated migration signaling. Li Y; Huang X; Wang C; Li Y; Luan M; Ma K Mol Med Rep; 2015 Apr; 11(4):2959-66. PubMed ID: 25503644 [TBL] [Abstract][Full Text] [Related]
4. Ganglioside GM3 inhibits hepatoma cell motility via down-regulating activity of EGFR and PI3K/AKT signaling pathway. Huang X; Li Y; Zhang J; Xu Y; Tian Y; Ma K J Cell Biochem; 2013 Jul; 114(7):1616-24. PubMed ID: 23355442 [TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of cMet tyrosine residues in murine ascitic hepatic cancer cell lines with different lymph node metastatic potentials. Li Y; Huang X; Zhang Q; Ma K Mol Med Rep; 2013 Aug; 8(2):655-61. PubMed ID: 23778885 [TBL] [Abstract][Full Text] [Related]
6. Gangliosides and CD82 inhibit the motility of colon cancer by downregulating the phosphorylation of EGFR at different tyrosine sites and signaling pathways. Huang X; Li Y; He X; Chen Y; Wei W; Yang X; Ma K Mol Med Rep; 2020 Nov; 22(5):3994-4002. PubMed ID: 33000220 [TBL] [Abstract][Full Text] [Related]
7. Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway. Todeschini AR; Dos Santos JN; Handa K; Hakomori SI Proc Natl Acad Sci U S A; 2008 Feb; 105(6):1925-30. PubMed ID: 18272501 [TBL] [Abstract][Full Text] [Related]
8. Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells. Usatyuk PV; Fu P; Mohan V; Epshtein Y; Jacobson JR; Gomez-Cambronero J; Wary KK; Bindokas V; Dudek SM; Salgia R; Garcia JG; Natarajan V J Biol Chem; 2014 May; 289(19):13476-91. PubMed ID: 24634221 [TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms. Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. Lee WJ; Wu LF; Chen WK; Wang CJ; Tseng TH Chem Biol Interact; 2006 Mar; 160(2):123-33. PubMed ID: 16458870 [TBL] [Abstract][Full Text] [Related]
11. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991 [TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis. Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320 [TBL] [Abstract][Full Text] [Related]
13. PHA665752 inhibits the HGF-stimulated migration and invasion of cells by blocking PI3K/AKT pathway in uveal melanoma. Wang Z; He C; Liu L; Ma N; Chen X; Zheng D; Qiu GH Neoplasma; 2017; 64(3):377-388. PubMed ID: 28253717 [TBL] [Abstract][Full Text] [Related]
14. Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells. Shi MD; Liao YC; Shih YW; Tsai LY Phytomedicine; 2013 Jun; 20(8-9):743-52. PubMed ID: 23537747 [TBL] [Abstract][Full Text] [Related]
15. Matriptase is required for the active form of hepatocyte growth factor induced Met, focal adhesion kinase and protein kinase B activation on neural stem/progenitor cell motility. Fang JD; Lee SL Biochim Biophys Acta; 2014 Jul; 1843(7):1285-94. PubMed ID: 24685580 [TBL] [Abstract][Full Text] [Related]
16. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway. Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813 [TBL] [Abstract][Full Text] [Related]
17. Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing. Xu KP; Yu FS Invest Ophthalmol Vis Sci; 2007 May; 48(5):2242-8. PubMed ID: 17460286 [TBL] [Abstract][Full Text] [Related]
18. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells. Wang SY; Chen B; Zhan YQ; Xu WX; Li CY; Yang RF; Zheng H; Yue PB; Larsen SH; Sun HB; Yang X J Hepatol; 2004 Aug; 41(2):267-73. PubMed ID: 15288476 [TBL] [Abstract][Full Text] [Related]
19. Ganglioside GM3 induces cumulus cell apoptosis through inhibition of epidermal growth factor receptor-mediated PI3K/AKT signaling pathways during in vitro maturation of pig oocytes. Park HJ; Chae SK; Kim JW; Yang SG; Jung JM; Kim MJ; Wee G; Lee DS; Kim SU; Koo DB Mol Reprod Dev; 2017 Aug; 84(8):702-711. PubMed ID: 28585705 [TBL] [Abstract][Full Text] [Related]
20. Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway. Matsushima-Nishiwaki R; Toyoda H; Takamatsu R; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Yoshimi N; Kumada T; Kozawa O Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1629-1639. PubMed ID: 28456666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]